---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-077227"
form_type: "8-K"
ticker: "QTTB"
cik: "0001661998"
company_name: "Q32 Bio Inc."
filed_at: "2022-03-16T23:59:59+00:00"
generated_at: "2026-06-26T22:23:32.321536+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Homology closes $130M AAV manufacturing JV with Oxford; retains 20% stake plus put/call option

## Summary
- Homology transferred AAV manufacturing assets to Newco for 175,000 units, then sold 130,000 units to OXB for $130M cash.
- OXB contributed $50M for 50,000 units; post-closing OXB owns 80%, Homology owns 20% of Newco.
- After three years, Homology can put (or OXB can call) Homology's Newco stake at 5.5x trailing revenue, subject to cap.
- Pro forma shows estimated gain of $145M on derecognition of assets and equity method investment of $45M as of Sept 30, 2021.

## SEC filing metadata
- accession: 0001193125-22-077227
- form_type: 8-K
- ticker: QTTB
- cik: 0001661998
- company_name: Q32 Bio Inc.
- filed_at: 2022-03-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661998/000119312522077227/0001193125-22-077227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661998/000119312522077227/d327212d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-077227
- JSON: https://secwatch.observer/filing/0001193125-22-077227.json
- Plain text: https://secwatch.observer/filing/0001193125-22-077227.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.